Characterization of tumor response with lenvatinib plus pembrolizumab in study 309/KEYNOTE-775

Makker, V; Lorusso, D; Moore, R; Miller, D; Mackay, H; Santin, A; Ushijima, K; Kim, YM; Sanli, U; Yonemori, K; Xie, R; Barresi, G; McKenzie, J; Colombo, N

GYNECOLOGIC ONCOLOGY, 2023; 176 (): S68